{
  "image_filename": "table_p7_det_6_000.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p7_det_6_000.png",
  "image_type": "Table",
  "page_number": 7,
  "block_id": "det_6_000",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A table summarizing contraindications and precautions for various influenza vaccine types (egg-based IIV or LAIV, cell culture\u2013based inactivated influenza vaccine [ccIIV], recombinant influenza vaccine [RIV], and unknown influenza vaccine) along with definitions of abbreviations. does not support the claim because the table addresses contraindications and precautions related to allergic reactions, not the potential for mutations during vaccine production and their impact on effectiveness.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table summarizing contraindications and precautions for various influenza vaccine types (egg-based IIV or LAIV, cell culture\u2013based inactivated influenza vaccine [ccIIV], recombinant influenza vaccine [RIV], and unknown influenza vaccine) along with definitions of abbreviations.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table addresses contraindications and precautions related to allergic reactions, not the potential for mutations during vaccine production and their impact on effectiveness.",
    "confidence_notes": null
  }
}